Article
T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors
8 Oct 2020
Abstract excerpt
The impressive success of chimeric antigen receptor (CAR)-T cell therapies in treating advanced B-cell malignancies has spurred a frenzy of activity aimed at developing CAR-T therapies for other cancers, particularly solid tumors, and optimizing engineered T cells for maximum clinical benefit in many different disease contexts. A rapidly growing body of design work is examining every modular component of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
